Overview
The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main questions this study aims to answer are
- What are the neonatal glycemic outcomes with use of AID systems during labor/delivery?
- Do patients report higher birth satisfaction with use of AID systems during labor/delivery?
- Are glycemic parameters like time-in-range (TIR) better with use of AID systems during labor/delivery?
Researchers will compare AID systems to intravenous (IV) insulin (the current standard of care for glucose management during labor/delivery) by randomly assigning participants to one or the other.
Eligibility
Inclusion Criteria:
- Known diagnosis of type 1 diabetes ≥ 1 year
- Current use of commercially available AID system ≥ 6 months
- Currently pregnant at ≥ 34 weeks
- Singleton pregnancy
- English- or Spanish-speaking
Exclusion Criteria:
- Planned cesarean delivery
- Use of medications known to interfere with glucose metabolism
- Intrauterine fetal demise
- Physical or psychological disease likely to interfere with the conduct of the study and/or the ability to participate in own healthcare